Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors. [electronic resource]
Producer: 20180223Description: 2315-22 p. digitalISSN:- 1534-4681
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Chemotherapy, Adjuvant
- Chemotherapy, Cancer, Regional Perfusion -- adverse effects
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cytoreduction Surgical Procedures -- adverse effects
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Hemorrhage -- etiology
- Humans
- Hyperthermia, Induced -- adverse effects
- Male
- Middle Aged
- Mitomycin -- administration & dosage
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Peritoneal Neoplasms -- pathology
- Postoperative Complications -- etiology
- Prognosis
- Risk Factors
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.